Where Care Excellence Meets Business Success. Transform your operations today - 0333 577 0877
We are here to help 24/7.

Awarded· 12 Mar 2025

Specialised Diagnostic testing for early invasive breast cancer pat

Somerset NHS Foundation Trust · Somerset, South West

Somerset NHS Foundation Trust has awarded Specialised Diagnostic testing for early invasive breast cancer pat. It is a contract for other health and social care in Somerset.

Source: Find a Tender, published 17 Mar 2025. Details are refreshed every 30 minutes.

Key dates

  1. 2025

    Contract awarded

    Exact Sciences

  2. 2025

    Award notice published

    Award Notice · 14:31

    View notice
01

About this tender

In brief

Somerset NHS Foundation Trust has awarded Specialised Diagnostic testing for early invasive breast cancer pat. It is a contract for other health and social care in Somerset. The contract went to Exact Sciences. It was awarded on 12 March 2025. The contract value is £184,950.

It is run as an award procedure without prior publication of a call for competition. Find a Tender published it on 17 March 2025. The notice number is 009688-2025. The OCDS ID is ocds-h6vhtk-04edea.

Summary of the contracting process

Somerset NHS Foundation Trust has awarded a contract for specialised diagnostic testing for early invasive breast cancer through the Provider Selection Regime (PSR) under the Health Care Services (Provider Selection Regime) Regulations 2023. The contract pertains to pathology services, specifically the Oncotype DX Breast Recurrence Score, and is taking place at Musgrove Park Hospital in Taunton, UK.

The procurement stage is the award, with the contract signed on 12 March 2025 and running until 11 March 2026. The contract, valued at £184,950, was awarded directly to Exact Sciences UK, Ltd. without prior publication of a call for competition. Winning such contracts can help expand their market presence and showcase their specialised capabilities in high-stakes healthcare environments.

The notice in full

The Oncotype DX Breast Recurrence Score.

Lots (1)

  1. 01

    Lot 1Cancelled

    Oncotype DX genomic testing for breast cancer.

    This notice is confirmation of an award having been made based on a framework agreement and without competition.

    The lifetime value of the contract is expected to be PS184,950.00.

    The contract dates are 12 March 2025 to 11 March 2026.

    This is an existing service with an existing provider.

02

Key facts

Every field the notice carries. Anything it leaves blank is listed under its table.

Contract

Service
Other health and social care
Procurement type
Standard
Category
Services
Contract period
Not specified - Not specified
Lots
1
Awarded to
Exact Sciences
Number of suppliers
1

Procedure

Notice type
Award Notice
Procurement method
Limited
Procedure
Award procedure without prior publication of a call for competition
Current stage
Award
Stages so far
Award
Published on
Find a Tender Service
Awardee scale
SME

Values

Contracts value
£184,950

Not stated in the notice: tender value, lots value, awards value.

Status

Tender
Complete
Lots
Cancelled
Awards
Active
Contracts
Active

References

Find a Tender notice
009688-2025
Open Contracting ID
ocds-h6vhtk-04edea
CPV code
85111800 - Pathology services
CPV division
85 - Health and social work services
03

Location

Somerset NHS Foundation Trust is based in Somerset. The area the service covers can be wider, so check the notice and the lots.
Local authority
Somerset
Town
Taunton
Postcode
TA1 5DA
Electoral ward
Bishop's Hull & Taunton West
Constituency
Taunton and Wellington
Delivery area
Somerset CC
Region
South West
Sub-region
Somerset
Area
North Somerset, Somerset and Dorset
Country
England
04

Buyer and supplier

Contracting authority

Organisation
Somerset NHS Foundation Trust
Category
Services
Contact
Hollie Caddy
Address
Taunton, TA1 5DA · South West · England

Not stated in the notice: phone.

Awarded supplier

Supplier
Exact Sciences
Awardee scale
SME
Number of suppliers
1
Awards value
Not stated
05

Documents and links

Official sources for this notice. The tender pack itself sits on the buyer's portal.
06

Questions about Specialised Diagnostic testing for early invasive breast cancer pat

Who won the Specialised Diagnostic testing for early invasive breast cancer pat contract?

Somerset NHS Foundation Trust awarded the contract to Exact Sciences on 12 March 2025.

How much is the Specialised Diagnostic testing for early invasive breast cancer pat contract worth?

The contract value is £184,950.

Who is the buyer for Specialised Diagnostic testing for early invasive breast cancer pat?

Somerset NHS Foundation Trust, based in Somerset, South West. The named contact is Hollie Caddy.

Get ready for the next round

Contracts like this come back. We help care providers build the evidence, policies and case studies a buyer scores, so you are ready when the re-tender opens.

What to do next

  1. This contract has been awarded.
  2. A re-tender usually follows near the end.
  3. Build your evidence and case studies now.
  4. Keep your policies and training records current.